Skip to Content
You are currently on the new version of our website. Access the old version .
VirusesViruses
  • Review
  • Open Access

9 June 2021

18 Pages

Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity

,
,
,
,
and
1
Department of Pediatrics, Weill Cornell Medicine, New York, NY 10065, USA
2
Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA
3
Center for Evolution & Medicine, School of Life Sciences, Arizona State University, Tempe, AZ 85281, USA
4
Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01655, USA
This article belongs to the Special Issue Cytomegalovirus Immunity 2021

Abstract

Human cytomegalovirus (HCMV), one of the most prevalent viruses across the globe, is a common cause of morbidity and mortality for immunocompromised individuals. Recent clinical observations have demonstrated that mixed strain infections are common and may lead to more severe disease progression. This clinical observation illustrates the complexity of the HCMV genome and emphasizes the importance of taking a population-level view of genotypic evolution. Here we review frequently sampled polymorphisms in the glycoproteins of HCMV, comparing the variable regions, and summarizing their corresponding geographic distributions observed to date. The related strain-specific immunity, including neutralization activity and antigen-specific cellular immunity, is also discussed. Given that these glycoproteins are common targets for vaccine design and anti-viral therapies, this observed genetic variation represents an important resource for future efforts to combat HCMV infections.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.